Trials / Completed
CompletedNCT01612689
3-Dimensional Accelerometer Sub-Study
3-Dimensional Accelerometer Sub-Study for Patients Participating in the E-30 Study: Heart Rate Changes in Subjects With Epilepsy During an Epilepsy Monitoring Unit Admission
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Cyberonics, Inc. · Industry
- Sex
- All
- Age
- 6 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, unblinded sub-study to the E-30 to gather physiological data.
Detailed description
This sub-study to the E-30 is designed to collect vital signs, accelerometer and ECG data on subjects, and will consist of two phases. Phase 1 is designed to collect data in an Epilepsy Monitoring Unit (EMU) and Phase 2 is designed to collect data in an everyday (ambulatory) setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Accelerometer Device | A sensor platform that enables physiological monitoring in routine, home or office environments. |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2012-10-01
- Completion
- 2014-07-01
- First posted
- 2012-06-06
- Last updated
- 2014-08-07
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01612689. Inclusion in this directory is not an endorsement.